A randomized prospective comparative study of weight gain between asenapine and iloperidone in patients with psychosis
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2017, Vol 7, Issue 1
Abstract
Background: Second-generation antipsychotics (SGAs) are better for psychotic disorders, and they can induce weight gain and other serious metabolic adverse effects which can lead to non-adherence and medical comorbidities. Iloperidone and asenapine, the newer SGAs with favorable short-term side effect profile. Aims and Objective: The aim of this study was to compare the weight gain propensity associated with new SGAs drugs-asenapine and iloperidone. Materials and Methods: Randomized prospective study was conducted from December 2014 to August 2015 in the Department of Psychiatry, Tertiary Care Hospital, Mysore. 60 patients who met the criteria for acute psychosis and schizophrenia according to ICD 10 were recruited. Atypical antipsychotics, asenapine (5-20 mg), and iloperidone (8-24 mg) were administered, and their weight was measured using the digital weighing scale on day 0 (baseline), week 1, week 3, and week 6. Results: Out of 60 recruited subjects, 51 (85%) completed all four visits of the study, 41.67% with asenapine, 43.3% with iloperidone. Mean weight gain was 2.18 ± 1.84 kg with iloperidone and 1.63 ± 1.28 kg with asenapine, but it was not statistically significant between the groups. Weight gain was dose dependent; 3.56 kg mean weight gain with 15-20 mg of asenapine and 3.36 kg with 18-24 mg iloperidone-treated patients which was statistically significant. Conclusion: Mild to moderate weight gain was seen in both asenapine and iloperidone and it was dose dependent. Iloperidone showed more weight gain than asenapine.
Authors and Affiliations
Nagesh HN, Anil Kumar Nagaraj, Narendra Kumar MS, Kishore MS
Keywords
Related Articles
- EP ID EP287937
- DOI 10.5455/njppp.2017.7.0721202082016
- Views 70
- Downloads 0
Importance of lipid-lipoprotein ratios as a diagnostic tool in metabolic syndrome population
Background: Metabolic syndrome (MS) is a constellation of diseases caused by several interconnected cardiometabolic risk factors such as obesity, hypertension, hyperglycemia, and dyslipidemia. Lipid-lipoprotein ratios ca...
Impact of stroke on quality of life and functional independence
Background: Cerebrovascular accident is the prime cause for the functional disability and deteriorated quality of life (QOL) which affects person’s social and physical capabilities. Present stroke outcomes are restricted...
Immediate effects of mobile phone radiations on heart rate variability in college going students
Background: The use of mobile phone has increased excessively these days which can have a deleterious effect on human tissues and organs, especially cardiovascular system (CVS). The effects on CVS can be detected at an e...
Assessment of knowledge, attitude, and practice of pharmacovigilance among doctors practicing alternative systems of medicine in Southern India: A questionnaire-based study
Background: Reporting adverse drug reactions (ADRs) are an essence of pharmacovigilance practice. Health-care professionals should know how and where to report an ADR. For Pharmacovigilance Programme of India (PVPI) to b...
Dapsone hypersensitivity syndrome - A case report
Dapsone is widely used for the treatment of leprosy and other immunological and inflammatory dermatological conditions such as dermatitis herpetiformis, vesiculobullous dermatoses, and pustular psoriasis. Dapsone hyperse...